Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) EPS (Weighted Average and Diluted): 2023-2024

Historic EPS (Weighted Average and Diluted) for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to -$5.58.

  • Upstream Bio's EPS (Weighted Average and Diluted) rose 90.95% to -$0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.69, marking a year-over-year increase of 146.10%. This contributed to the annual value of -$5.58 for FY2024, which is 56.91% up from last year.
  • Per Upstream Bio's latest filing, its EPS (Weighted Average and Diluted) stood at -$5.58 for FY2024, which was up 56.91% from -$12.95 recorded in FY2023.
  • Upstream Bio's 5-year EPS (Weighted Average and Diluted) high stood at -$5.58 for FY2024, and its period low was -$12.95 during FY2023.
  • Moreover, its 2-year median value for EPS (Weighted Average and Diluted) was -$9.27 (2023), whereas its average is -$9.27.
  • Data for Upstream Bio's EPS (Weighted Average and Diluted) shows a peak YoY surged of 56.91% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Upstream Bio's EPS (Weighted Average and Diluted) stood at -$12.95 in 2023, then soared by 56.91% to -$5.58 in 2024.